Starting at $149
Not every compounded GLP-1 platform carries the same level of regulatory risk
CrossRef An umbrella meta-analysis of microbial therapy on hepatic steatosis, fibrosis, and liver stiffness in metabolic dysfunction-associated steatotic liver disease Gvzalnur Kurban, Xiangjun Chen, Xingyi Jin, Hui Xia, Shaokang Wang, Guiju Sun Frontiers in Nutrition .2025;[Epub] CrossRef Linking bisphenol a exposure to MASLD: insights from network toxicology and machine learning based on NHANES 20052012 data Jiaquan Yuan, Haoyang Xu, Junhong Gan, Haiyan Zhao Toxicology Research .2025;[Epub] CrossRef Curcumin and Tetrahydrocurcumin as Multi-Organ Modulators of the Adipose TissueGutLiver Axis: Mechanistic Insights, Therapeutic Potential, and Translational Challenges Marina Konaktchieva, Radoslav Stojchevski, Nikola Hadzi-Petrushev, Hristo Gagov, Rositza Konakchieva, Vadim Mitrokhin, Gjoko Kungulovski, Mitko Mladenov, Dimiter Avtanski Pharmaceuticals .2025
[DOI] [PubMed] [Google Scholar] 130.Cojoc M., Peitzsch C., Kurth I., Trautmann F., Kunz-Schughart L.A., Telegeev G.D., Stakhovsky E.A., Walker J.R., Simin K., Lyle S., et al
